Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fitzmaurice

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 9, 2016
Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative studyIan Litchfield, David Fitzmaurice, Patricia Apenteng, et al.
BMJ Open|December 16, 2016
Patients' perceptions and experiences of the prevention of hospital-acquired thrombosis: a qualitative studyPatricia N Apenteng, David Fitzmaurice, Ian Litchfield, et al.
BMJ Open|May 8, 2016
Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTEJoie Ensor, Richard D Riley, David Moore, et al.
British Journal of Haematology|August 30, 2006
Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysisSue Jowett, Stirling Bryan, Ellen Murray, et al.
Systematic Reviews|June 20, 2015
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic reviewDanai Bem, Janine Dretzke, Simon Stevens, et al.
Family Practice|May 31, 2007
An analysis of factors that predict patient consent to take part in a randomized controlled trialKate Fletcher, Jonathan Mant, Roger Holder, et al.
Systematic Reviews|December 4, 2014
Methodological issues and recommendations for systematic reviews of prognostic studies: an example from cardiovascular diseaseJanine Dretzke, Joie Ensor, Sue Bayliss, et al.
Plos Medicine|November 16, 2016
Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective AnalysisGrace M Turner, Melanie Calvert, Max G Feltham, et al.
BMC Cardiovascular Disorders|March 19, 2013
Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study)Jayne Tullett, Ellen Murray, Linda Nichols, et al.
Stroke|August 7, 2014
Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)"Nahal Mavaddat, Andrea Roalfe, Kate Fletcher, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 9, 2016
Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative studyIan Litchfield, David Fitzmaurice, Patricia Apenteng, et al.
BMJ Open|December 16, 2016
Patients' perceptions and experiences of the prevention of hospital-acquired thrombosis: a qualitative studyPatricia N Apenteng, David Fitzmaurice, Ian Litchfield, et al.
BMJ Open|May 8, 2016
Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTEJoie Ensor, Richard D Riley, David Moore, et al.
British Journal of Haematology|August 30, 2006
Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysisSue Jowett, Stirling Bryan, Ellen Murray, et al.
Systematic Reviews|June 20, 2015
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic reviewDanai Bem, Janine Dretzke, Simon Stevens, et al.
Family Practice|May 31, 2007
An analysis of factors that predict patient consent to take part in a randomized controlled trialKate Fletcher, Jonathan Mant, Roger Holder, et al.
Systematic Reviews|December 4, 2014
Methodological issues and recommendations for systematic reviews of prognostic studies: an example from cardiovascular diseaseJanine Dretzke, Joie Ensor, Sue Bayliss, et al.
Plos Medicine|November 16, 2016
Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective AnalysisGrace M Turner, Melanie Calvert, Max G Feltham, et al.
BMC Cardiovascular Disorders|March 19, 2013
Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study)Jayne Tullett, Ellen Murray, Linda Nichols, et al.
Stroke|August 7, 2014
Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)"Nahal Mavaddat, Andrea Roalfe, Kate Fletcher, et al.
Pageof 8